Marcyrl to produce three new types of Hep-C meds locally in 2017

Marcyrl Pharma Industries intends to start locally producing three new types of meds that treat Hepatitis-C in 2017, Al Borsa says. Company President Magdy Mounir said that Hep-C meds will not be increasing in price, despite the surge in the FX rate, especially as their domestic production picks up.